Selected article for: "oxygenation therapy and respiratory failure"
Author: Firstenberg, Michael S.; Libby, Matthew; Roberts, Rachele; Petersen, Courtney; Hanna, Jennifer
Title: Complete pulmonary recovery after COVID-19 infection requiring extracorporeal membrane oxygenation: A case report
  • Cord-id: xh81086k
  • Document date: 2020_9_22
    • ID: xh81086k
    Snippet: Severe pulmonary complications associated with COVID-19 infections are a substantial source of morbidity and/or mortality. Extracorporeal membrane oxygenation (ECMO) has been shown to be a potentially useful therapy in the management of severe COVID-19 infection as a means to facilitate pulmonary recovery. Despite growing evidence to demonstrate the utility of ECMO for COVID-19 respiratory failure, little is known regarding the posthospital discharge recovery and functional status of these patie
    Document: Severe pulmonary complications associated with COVID-19 infections are a substantial source of morbidity and/or mortality. Extracorporeal membrane oxygenation (ECMO) has been shown to be a potentially useful therapy in the management of severe COVID-19 infection as a means to facilitate pulmonary recovery. Despite growing evidence to demonstrate the utility of ECMO for COVID-19 respiratory failure, little is known regarding the posthospital discharge recovery and functional status of these patients. Furthermore, concerns regarding potential long-term complications, but data are lacking. We illustrate a case of a previously healthy male, who was supported on ECMO for severe COVID-19 who demonstrated what appears to be a complete subjective and objective pulmonary recovery within a short time postdischarge. Our case provides some optimisms that critically-ill COVID-19 patients might recover completely and be able to return to functional lives.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory failure and admission laboratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory failure and liver transaminase: 1
    • acute respiratory failure and long term effect: 1
    • acute respiratory failure and long term morbidity: 1, 2, 3
    • acute respiratory failure and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute respiratory failure and lung protective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • acute respiratory failure and lung protective strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory failure cause and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory failure cause and lung protective: 1, 2
    • acute respiratory failure cause and lung protective strategy: 1
    • additional unit and lung injury: 1
    • admission laboratory and long term effect: 1
    • admission laboratory and lung injury: 1, 2, 3
    • admission laboratory and lung protective: 1
    • liver transaminase and lung injury: 1
    • long term effect and lung injury: 1
    • long term effect and lung protective: 1
    • long term morbidity and lung injury: 1, 2, 3, 4